Biogen (BIIB) Draws Takeover Interest from Allergan (AGN), Merck (MRK) - DJ
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
(Updated - August 2, 2016 2:49 PM EDT)
Biogen (Nasdaq: BIIB) attracted takeover interest from Allergan (NYSE: AGN) and Merck (NYSE: MRK), according to Dow Jones, citing sources. The two companies reportedly "sounded out" Biogen on a possible takeover.
Communications were informal and preliminary, and may not result in a deal in part because Biogen may not be interested.
Takeover chatter on Biogen recently picked up after long-time CEO, George Scangos, announced plans to step down in July.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Varonis Said To Weigh Sale After Takeover Interest - Bloomberg
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- UWMC urges Two Harbors stockholders to reject CCM merger deal
Create E-mail Alert Related Categories
Hot M&A, Mergers and Acquisitions, Reuters, Rumors, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
